Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GFN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,688
Award facts
- Contract value 100% obligated
- $32,687.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,687.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 mL pen injectors on January 13, 2026, with a completion date of January 14, 2026. This is a non-set-aside competitive award with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2031, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
Kesimpta is a specialty pharmaceutical used in the treatment of multiple sclerosis, reflecting the broad therapeutic portfolio that AmerisourceBergen supplies to federal military and healthcare systems through its DLA contract vehicle. As a major pharmaceutical distributor, AmerisourceBergen leverages its established IDC relationship with DLA to fulfill discrete task orders for specific medications and medical supplies needed across Department of Defense healthcare facilities and military treatment centers. The non-set-aside competitive award structure demonstrates the contractor's capability to meet federal procurement requirements through open competition against other qualified pharmaceutical distributors.
Quick answers
Who was awarded contract SPE2DR26F1GFN?
SPE2DR26F1GFN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1GFN worth?
The government has obligated $32,688 on SPE2DR26F1GFN.
Is contract SPE2DR26F1GFN an order under another contract?
Yes. SPE2DR26F1GFN is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GFN competed?
The extent of competition for SPE2DR26F1GFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award